Studied in randomised Phase III clinical trials, evaluating efficacy and dosing compared to placebo.
Generally well tolerated
Comprehensive pre-clinical programme examining toxicity, drug-drug interactions, pharmacology, dosing and abuse potential; as well as extensive clinical trials.
Manufactured to GxP standards and complies with regulatory medicine standards, ensuring:
- Freedom from contaminants such as pesticides, heavy metals and aflatoxins
- Batch-to-batch consistency
- A stable shelf life
- Continuous investment in process and facilities
GxP, Good Practice.